Poster: MM-181 CARTITUDE-1: Two-Year Post Last Patient in (LPI) Results From the Phase 1b/2 Study of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

Authors :: Saad Z Usmani
Thomas Martin
Jesus G Berdeja
Andrzej Jakubowiak
Mounzer Agha
Adam D Cohen
Abhinav Deol
Myo Htut
Alexander Lesokhin
Nikhil C Munshi
Elizabeth O'Donnell
Carolyn C Jackson
Tzu-min Yeh
Arnob Banerjee
Enrique Zudaire
Deepu Madduri
Changwei Zhou
Lida Pacaud
Yi Lin
Sundar Jagannath
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S179
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools